Market Value125,523,000
Total Holdings57
File Date2017-02-14
Original Filing (Click here)

All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings. These reports are called 13F reports. However, the filings are required the following quarter from the reporting period, which means that by the time the filing is made (and we see them), the information could be five months old.

For funds with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover, the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions are identified in the table. However, they are not required to report short positions.

Click the link icon to see the full transaction history.

Upgrade to unlock premium data and export to Excel .

Security Imputed
Share Price
Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
(USD x1000)
Current Value
(USD x1000)
Change
(Percent)
AGIO / Agios Pharmaceuticals, Inc.
TSRO / TESARO, Inc.
MRK / Merck & Co., Inc.
ISEE / IVERIC bio Inc
IOVA / Iovance Biotherapeutics, Inc.
CLVS / Clovis Oncology Inc
SIOX / Sio Gene Therapies Inc.
PCRX / Pacira BioSciences, Inc.
SDS / ProShares Trust - ProShares UltraShort S&P500
JUNO / Juno Therapeutics, Inc.
MYGN / Myriad Genetics, Inc.
PRTK / Paratek Pharmaceuticals Inc.
LLY / Eli Lilly and Company Call
XBI / SPDR Series Trust - SPDR S&P Biotech ETF Call
CPHD / Cepheid
BIB / ProShares Trust - ProShares Ultra Nasdaq Biotechnology
CFRX / ContraFect Corp
AZN / AstraZeneca PLC - Depositary Receipt (Common Stock)
SNR / New Senior Investment Group Inc
IWM / iShares Trust - iShares Russell 2000 ETF Put
AVXS / AveXis, Inc.
MDCO / Medicines Company
US0153511094 / Alexion Pharmaceuticals, Inc.
XBI / SPDR Series Trust - SPDR S&P Biotech ETF
XBI / SPDR Series Trust - SPDR S&P Biotech ETF Put
PGEN / Precigen, Inc.
MCRB / Seres Therapeutics, Inc.
0PP / Portola Pharmaceuticals Inc
NVAX / Novavax, Inc.
PFE / Pfizer Inc.
REPH / Societal CDMO Inc
BMRN / BioMarin Pharmaceutical Inc.
ADMS / Adamas Pharmaceuticals Inc
KITE / Kite Pharma, Inc.
BMY / Bristol-Myers Squibb Company Call
IQV / IQVIA Holdings Inc.
CRL / Charles River Laboratories International, Inc.
GSK / GSK plc - Depositary Receipt (Common Stock)
VRTX / Vertex Pharmaceuticals Incorporated
ACAD / ACADIA Pharmaceuticals Inc.
ALKS / Alkermes plc
IBB / iShares Trust - iShares Biotechnology ETF
NKTR / Nektar Therapeutics
CELG / Celgene Corp.
GRFS / Grifols, S.A. - Depositary Receipt (Common Stock)
SGEN / Seagen Inc
INCY / Incyte Corporation
GILD / Gilead Sciences, Inc.
NBIX / Neurocrine Biosciences, Inc.
TECH / Bio-Techne Corporation
RARE / Ultragenyx Pharmaceutical Inc.
ICPT / Intercept Pharmaceuticals Inc
AMGN / Amgen Inc.
ILMN / Illumina, Inc.
LABU / Direxion Shares ETF Trust - Direxion Daily S&P Biotech Bull 3X Shares
IONS / Ionis Pharmaceuticals, Inc.
LGND / Ligand Pharmaceuticals Incorporated
REGN / Regeneron Pharmaceuticals, Inc.
BIIB / Biogen Inc.
QGEN / Qiagen N.V.
MTD / Mettler-Toledo International Inc.
BMY / Bristol-Myers Squibb Company
ALNY / Alnylam Pharmaceuticals, Inc.
UTHR / United Therapeutics Corporation